Simeprevir
Oral HCV-PROTEASE INHIBITOR effective against hepatitis C virus (HCV) serine protease NS3/4A. It is used in the treatment of chronic hepatitis C (Antivirals) genotype 1 infection in adults with compensated liver disease, including CIRRHOSIS.
Year introduced: 2016 (2008)
PubMed search builder options
Subheadings:
Tree Number(s): D02.886.590.700.700, D03.633.300.819
MeSH Unique ID: D000069616
Registry Number: 9WS5RD66HZ
Entry Terms:
- N-(17-(2-(4-isopropylthiazole-2-yl)-7-methoxy-8-methylquinolin-4-yloxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo(13.3.0.04,6)octadec-7-ene-4-carbonyl)(cyclopropyl)sulfonamide
- TMC 435350
- 435350, TMC
- TMC-435350
- TMC435350
- TMC 435
- 435, TMC
- TMC-435
- TMC435
- Olysio
Pharmacologic Action: